25 years since the discovery of presynaptic receptors: present knowledge and future perspectives.
about
Clonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skinPeripheral and central effects of circulating catecholaminesClonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activationRole of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor functionDopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatumRelease of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder.Compartmental localization of gamma-aminobutyric acid type B receptors in the cholinergic circuitry of the rabbit retina.Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.Modeling Starburst cells' GABA(B) receptors and their putative role in motion sensitivity.Pharmacological analysis of functional neurovascular transmission in canine splenic arteries: role of neuropeptide Y.Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.Subcellular distribution of M2 muscarinic receptors in relation to dopaminergic neurons of the rat ventral tegmental areaPeptides' role in autism with emphasis on exorphins.Postoperative ileus: mechanisms and future directions for research.Stable RNA interference of synaptotagmin I in PC12 cells results in differential regulation of transmitter release.Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.Coordinated regulation of cholinergic motor neuron traits through a conserved terminal selector gene.Relationship between L-DOPA-induced reduction in motor and exploratory activity and degree of DAT binding in the rat.Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells)Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids-Cannabinoids and Acute Stress Modulate GABA Release.Effects of L-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat.Behavioural and physiological effects induced by an infusion of antisense to alpha(2D)-adrenoceptors in the rat.Presynaptic alpha2-adrenoceptor-mediated modulation of adenosine 5' triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein.Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release.A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels.Neuropeptide Y inhibits double peaked vasoconstrictor responses to periarterial nerve stimulation primarily through prejunctional Y2 receptor subtype in canine splenic arteries.The effects of hypochlorite-induced oxidative stress on presynaptic M2-receptors at sympathetic nerve endings in the rat tail artery.Noradrenergic modulation of XII motoneuron inspiratory activity does not involve alpha2-receptor inhibition of the Ih current or presynaptic glutamate release.Contrasting effects of presynaptic alpha2-adrenergic autoinhibition and pharmacologic augmentation of presynaptic inhibition on sympathetic heart rate control.A search for presynaptic beta3-adrenoceptors in the rat.Release-enhancing pre-synaptic muscarinic and nicotinic receptors co-exist and interact on dopaminergic nerve endings of rat nucleus accumbens.Interactions between β-adrenergic vasodilation and cervical sympathetic nerves are mediated by α2-adrenoceptors in the rat masseter muscle.Pharmacological characterisation of the electrically evoked release of monoamines from chicken brain in vitro.Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions.Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.Insights into the structure and function of 5-HT(2) family serotonin receptors reveal novel strategies for therapeutic target development.Inhibition of sympathetic pathways restores postoperative ileus in the upper and lower gastrointestinal tract.Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.Physiological activation of presynaptic metabotropic glutamate receptors increases intracellular calcium and glutamate release.
P2860
Q28184792-A675417F-D686-41DB-842E-BF1285F953D0Q28255579-7B9F2931-A221-4ACF-932A-8AAF801C1497Q28362700-AB639EE4-F85B-4BBC-816A-C7B86908F151Q28478336-730DC10B-063B-4234-A7FE-09D2D4D99C4DQ28585149-13D6314C-925A-4906-8252-0397F4100645Q31111758-5FFF0D4D-5239-408F-A505-75757BF60775Q33769891-B738EF77-6F1F-4E8C-AFBD-B03F3BCD8004Q33955584-F06581F0-586A-4421-8C2B-2419E7FDCF8FQ34698591-1FAD7952-82D9-4B21-ABDC-483719FA051BQ35092041-1F321918-923D-4D12-8339-F059BABF65C7Q35693323-14790C5C-C87A-4E7F-8FED-CDD1C6956037Q36958750-DAD3336A-579F-447C-BA22-8621E2106142Q37106089-0DE8DE06-4FC4-4DC8-83FF-6923A5CEB42EQ38206266-75F6749D-B1DE-4988-8D78-38C2CD49976BQ40072463-9A62F33B-BE3C-42CA-A662-30F5E464CDC7Q40577984-BA3AF5AE-D288-4F76-BE73-5185821CBE03Q40715368-7DA21D5D-327B-4B9C-B235-57EA76455CBDQ41979764-C2749AFD-FD7B-45CC-A7B1-F2C9DFE2BF65Q42508016-903D1B43-90E2-4DE8-BA2A-1559E8B5D688Q42825579-9C8AB73F-10C9-4492-A311-48403F51F190Q42924776-8AC63119-01A4-4333-88FC-5834D7EBB2C6Q43264182-F30D4708-F67A-433E-B4A2-BB8E118BAE8CQ43651067-8A545650-3018-40A0-A880-BA0F4543F9B4Q43884678-1541F9B3-E54F-4C1B-8BB4-C5C51E68B15DQ43910738-ECE08D5C-1FE1-4974-B38D-A2ED20D9CB4DQ44302974-4BD5EC32-1D10-423F-812E-A39E88637A23Q44302976-D1B22D03-C376-4674-95C4-5BD6941C3B37Q45173465-02CBEBEC-5A2D-4FA8-AF3D-F0D4E241FA4EQ46403684-20118229-D439-4978-A358-F9B4DF33C573Q46422418-89A0DF06-23E6-49F5-82C7-3D36F85517A3Q46734842-52EF595F-F4E5-4DBC-9BC7-BD7AD5CE7918Q48236965-E48225E3-BA2F-41D2-89FF-B932F57822A9Q48239188-894B2C61-8DCD-4734-A688-C19D6476AF63Q48309573-6B8B1EFE-2ED3-4D60-B664-3E4F8B99D4D7Q48357561-2C56CBAD-B3DB-40DC-9B77-EF66104E3BC3Q48404127-59666935-4CC7-4F48-B4C4-3F82E21591C4Q48575668-FB38E9D2-184E-4576-989B-6E13E33DAF5DQ48766388-93E3B1CE-54A6-402C-94B9-962BF1F4C7CBQ51391474-A914C031-E689-45DF-BAB3-68A8F5372D49
P2860
25 years since the discovery of presynaptic receptors: present knowledge and future perspectives.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
25 years since the discovery o ...... ledge and future perspectives.
@en
type
label
25 years since the discovery o ...... ledge and future perspectives.
@en
prefLabel
25 years since the discovery o ...... ledge and future perspectives.
@en
P1476
25 years since the discovery o ...... ledge and future perspectives.
@en
P2093
P356
10.1016/S0165-6147(96)01034-6
P577
1997-03-01T00:00:00Z